Related Experiment Video
Updated: Apr 23, 2026
02:28
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
1.1K
Psoriasis and metabolic syndrome
1Tiago Torres, MD, Serviço de Dermatologia , Centro Hospitalar do Porto , Rua D. Manuel II s/n Ex. CICAP, 4099-001 Porto, Portugal; tiagotorres2002@hotmail.com.
Acta Dermatovenerologica Croatica : ADC
|September 18, 2014
Summary
Psoriasis patients have a high prevalence of metabolic syndrome, increasing cardiovascular risks. Early screening for cardiometabolic disorders in psoriasis patients is crucial for comprehensive management.
Area of Science:
- Dermatology
- Cardiology
- Endocrinology
Background:
- Psoriasis is a chronic inflammatory disease with significant cardiometabolic comorbidities.
- These include obesity, insulin resistance, dyslipidemia, and hypertension, which are components of metabolic syndrome.
- Psoriasis patients exhibit a higher prevalence of metabolic syndrome compared to other dermatological conditions.
Purpose of the Study:
- To review the range of cardiometabolic comorbidities associated with psoriasis.
- To emphasize the link between psoriasis and metabolic syndrome.
- To encourage physicians to screen psoriasis patients for cardiometabolic risks.
Main Methods:
- Literature review of epidemiologic studies and relevant research.
- Analysis of the interrelationship between psoriasis and metabolic syndrome.
- Focus on genetic and inflammatory pathways potentially linking the conditions.
Main Results:
- Psoriasis is strongly associated with metabolic syndrome and increased cardiovascular risk.
- Overlapping inflammatory pathways and genetic factors may underlie this association.
- High prevalence of metabolic syndrome in psoriasis patients is consistently reported.
Conclusions:
- Understanding the link between psoriasis and metabolic syndrome is vital for patient management.
- Physicians should proactively screen psoriasis patients for cardiometabolic disorders.
- Early detection and management can mitigate cardiovascular risks in psoriasis patients.
Related Concept Videos
01:24Overview of Lipid Metabolism
6.8K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.8K
01:26Type I Diabetes II: Pathophysiology
42
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
42
01:24Type II Diabetes II: Pathophysiology
8
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
8
01:23Skin Diseases and Disorders
5.1K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.1K
01:26Type II Diabetes I: Introduction
8
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
8
01:19Multiple Sclerosis l: Introduction
9
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
9